The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Agomelatine Market Research Report 2024
Synopsis
Agomelatine is structurally closely related to melatonin. Agomelatine is a potent agonist at melatonin receptors and an antagonist at serotonin-2C (5-HT2C) receptors, tested in an animal model of depression.
The global Agomelatine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Agomelatine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Agomelatine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Agomelatine include Servier, Rovi Pharma, Novartis, Nectid Inc and Jiangsu Haosen Pharmaceutical Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Agomelatine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Agomelatine.
Report Scope
The Agomelatine market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Agomelatine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Agomelatine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Servier
Rovi Pharma
Novartis
Nectid Inc
Jiangsu Haosen Pharmaceutical Group
Segment by Type
Serotonin 2C Agonist
Melatonin Receptor 2 Agonist
Melatonin Receptor 1 Agonist
Serotonin Receptor Agonist
Serotonin 2C Receptor Antagonist
Segment by Application
Depression
Obsessive Compulsive Disorder
Sleep Disorders
Generalized Anxiety Disorder
Multiple Sclerosis
Systemic Traumatic Pain
Autism
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Agomelatine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Agomelatine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Agomelatine is structurally closely related to melatonin. Agomelatine is a potent agonist at melatonin receptors and an antagonist at serotonin-2C (5-HT2C) receptors, tested in an animal model of depression.
The global Agomelatine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Agomelatine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Agomelatine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Agomelatine include Servier, Rovi Pharma, Novartis, Nectid Inc and Jiangsu Haosen Pharmaceutical Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Agomelatine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Agomelatine.
Report Scope
The Agomelatine market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Agomelatine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Agomelatine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Servier
Rovi Pharma
Novartis
Nectid Inc
Jiangsu Haosen Pharmaceutical Group
Segment by Type
Serotonin 2C Agonist
Melatonin Receptor 2 Agonist
Melatonin Receptor 1 Agonist
Serotonin Receptor Agonist
Serotonin 2C Receptor Antagonist
Segment by Application
Depression
Obsessive Compulsive Disorder
Sleep Disorders
Generalized Anxiety Disorder
Multiple Sclerosis
Systemic Traumatic Pain
Autism
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Agomelatine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Agomelatine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Agomelatine Market Overview
1.1 Product Overview and Scope of Agomelatine
1.2 Agomelatine Segment by Type
1.2.1 Global Agomelatine Market Value Comparison by Type (2024-2030)
1.2.2 Serotonin 2C Agonist
1.2.3 Melatonin Receptor 2 Agonist
1.2.4 Melatonin Receptor 1 Agonist
1.2.5 Serotonin Receptor Agonist
1.2.6 Serotonin 2C Receptor Antagonist
1.3 Agomelatine Segment by Application
1.3.1 Global Agomelatine Market Value by Application: (2024-2030)
1.3.2 Depression
1.3.3 Obsessive Compulsive Disorder
1.3.4 Sleep Disorders
1.3.5 Generalized Anxiety Disorder
1.3.6 Multiple Sclerosis
1.3.7 Systemic Traumatic Pain
1.3.8 Autism
1.3.9 Other
1.4 Global Agomelatine Market Size Estimates and Forecasts
1.4.1 Global Agomelatine Revenue 2019-2030
1.4.2 Global Agomelatine Sales 2019-2030
1.4.3 Global Agomelatine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Agomelatine Market Competition by Manufacturers
2.1 Global Agomelatine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Agomelatine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Agomelatine Average Price by Manufacturers (2019-2024)
2.4 Global Agomelatine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Agomelatine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Agomelatine, Product Type & Application
2.7 Agomelatine Market Competitive Situation and Trends
2.7.1 Agomelatine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Agomelatine Players Market Share by Revenue
2.7.3 Global Agomelatine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Agomelatine Retrospective Market Scenario by Region
3.1 Global Agomelatine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Agomelatine Global Agomelatine Sales by Region: 2019-2030
3.2.1 Global Agomelatine Sales by Region: 2019-2024
3.2.2 Global Agomelatine Sales by Region: 2025-2030
3.3 Global Agomelatine Global Agomelatine Revenue by Region: 2019-2030
3.3.1 Global Agomelatine Revenue by Region: 2019-2024
3.3.2 Global Agomelatine Revenue by Region: 2025-2030
3.4 North America Agomelatine Market Facts & Figures by Country
3.4.1 North America Agomelatine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Agomelatine Sales by Country (2019-2030)
3.4.3 North America Agomelatine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Agomelatine Market Facts & Figures by Country
3.5.1 Europe Agomelatine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Agomelatine Sales by Country (2019-2030)
3.5.3 Europe Agomelatine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Agomelatine Market Facts & Figures by Country
3.6.1 Asia Pacific Agomelatine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Agomelatine Sales by Country (2019-2030)
3.6.3 Asia Pacific Agomelatine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Agomelatine Market Facts & Figures by Country
3.7.1 Latin America Agomelatine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Agomelatine Sales by Country (2019-2030)
3.7.3 Latin America Agomelatine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Agomelatine Market Facts & Figures by Country
3.8.1 Middle East and Africa Agomelatine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Agomelatine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Agomelatine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Agomelatine Sales by Type (2019-2030)
4.1.1 Global Agomelatine Sales by Type (2019-2024)
4.1.2 Global Agomelatine Sales by Type (2025-2030)
4.1.3 Global Agomelatine Sales Market Share by Type (2019-2030)
4.2 Global Agomelatine Revenue by Type (2019-2030)
4.2.1 Global Agomelatine Revenue by Type (2019-2024)
4.2.2 Global Agomelatine Revenue by Type (2025-2030)
4.2.3 Global Agomelatine Revenue Market Share by Type (2019-2030)
4.3 Global Agomelatine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Agomelatine Sales by Application (2019-2030)
5.1.1 Global Agomelatine Sales by Application (2019-2024)
5.1.2 Global Agomelatine Sales by Application (2025-2030)
5.1.3 Global Agomelatine Sales Market Share by Application (2019-2030)
5.2 Global Agomelatine Revenue by Application (2019-2030)
5.2.1 Global Agomelatine Revenue by Application (2019-2024)
5.2.2 Global Agomelatine Revenue by Application (2025-2030)
5.2.3 Global Agomelatine Revenue Market Share by Application (2019-2030)
5.3 Global Agomelatine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Servier
6.1.1 Servier Corporation Information
6.1.2 Servier Description and Business Overview
6.1.3 Servier Agomelatine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Servier Agomelatine Product Portfolio
6.1.5 Servier Recent Developments/Updates
6.2 Rovi Pharma
6.2.1 Rovi Pharma Corporation Information
6.2.2 Rovi Pharma Description and Business Overview
6.2.3 Rovi Pharma Agomelatine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Rovi Pharma Agomelatine Product Portfolio
6.2.5 Rovi Pharma Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Agomelatine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Agomelatine Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Nectid Inc
6.4.1 Nectid Inc Corporation Information
6.4.2 Nectid Inc Description and Business Overview
6.4.3 Nectid Inc Agomelatine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nectid Inc Agomelatine Product Portfolio
6.4.5 Nectid Inc Recent Developments/Updates
6.5 Jiangsu Haosen Pharmaceutical Group
6.5.1 Jiangsu Haosen Pharmaceutical Group Corporation Information
6.5.2 Jiangsu Haosen Pharmaceutical Group Description and Business Overview
6.5.3 Jiangsu Haosen Pharmaceutical Group Agomelatine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Jiangsu Haosen Pharmaceutical Group Agomelatine Product Portfolio
6.5.5 Jiangsu Haosen Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Agomelatine Industry Chain Analysis
7.2 Agomelatine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Agomelatine Production Mode & Process
7.4 Agomelatine Sales and Marketing
7.4.1 Agomelatine Sales Channels
7.4.2 Agomelatine Distributors
7.5 Agomelatine Customers
8 Agomelatine Market Dynamics
8.1 Agomelatine Industry Trends
8.2 Agomelatine Market Drivers
8.3 Agomelatine Market Challenges
8.4 Agomelatine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Agomelatine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Agomelatine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Agomelatine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Agomelatine Sales (M Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Agomelatine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Agomelatine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Agomelatine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Agomelatine Average Price (US$/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Agomelatine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Agomelatine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Agomelatine, Product Type & Application
Table 12. Global Key Manufacturers of Agomelatine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Agomelatine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Agomelatine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Agomelatine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Agomelatine Sales by Region (2019-2024) & (M Pcs)
Table 18. Global Agomelatine Sales Market Share by Region (2019-2024)
Table 19. Global Agomelatine Sales by Region (2025-2030) & (M Pcs)
Table 20. Global Agomelatine Sales Market Share by Region (2025-2030)
Table 21. Global Agomelatine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Agomelatine Revenue Market Share by Region (2019-2024)
Table 23. Global Agomelatine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Agomelatine Revenue Market Share by Region (2025-2030)
Table 25. North America Agomelatine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Agomelatine Sales by Country (2019-2024) & (M Pcs)
Table 27. North America Agomelatine Sales by Country (2025-2030) & (M Pcs)
Table 28. North America Agomelatine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Agomelatine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Agomelatine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Agomelatine Sales by Country (2019-2024) & (M Pcs)
Table 32. Europe Agomelatine Sales by Country (2025-2030) & (M Pcs)
Table 33. Europe Agomelatine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Agomelatine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Agomelatine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Agomelatine Sales by Region (2019-2024) & (M Pcs)
Table 37. Asia Pacific Agomelatine Sales by Region (2025-2030) & (M Pcs)
Table 38. Asia Pacific Agomelatine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Agomelatine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Agomelatine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Agomelatine Sales by Country (2019-2024) & (M Pcs)
Table 42. Latin America Agomelatine Sales by Country (2025-2030) & (M Pcs)
Table 43. Latin America Agomelatine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Agomelatine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Agomelatine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Agomelatine Sales by Country (2019-2024) & (M Pcs)
Table 47. Middle East & Africa Agomelatine Sales by Country (2025-2030) & (M Pcs)
Table 48. Middle East & Africa Agomelatine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Agomelatine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Agomelatine Sales (M Pcs) by Type (2019-2024)
Table 51. Global Agomelatine Sales (M Pcs) by Type (2025-2030)
Table 52. Global Agomelatine Sales Market Share by Type (2019-2024)
Table 53. Global Agomelatine Sales Market Share by Type (2025-2030)
Table 54. Global Agomelatine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Agomelatine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Agomelatine Revenue Market Share by Type (2019-2024)
Table 57. Global Agomelatine Revenue Market Share by Type (2025-2030)
Table 58. Global Agomelatine Price (US$/Pcs) by Type (2019-2024)
Table 59. Global Agomelatine Price (US$/Pcs) by Type (2025-2030)
Table 60. Global Agomelatine Sales (M Pcs) by Application (2019-2024)
Table 61. Global Agomelatine Sales (M Pcs) by Application (2025-2030)
Table 62. Global Agomelatine Sales Market Share by Application (2019-2024)
Table 63. Global Agomelatine Sales Market Share by Application (2025-2030)
Table 64. Global Agomelatine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Agomelatine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Agomelatine Revenue Market Share by Application (2019-2024)
Table 67. Global Agomelatine Revenue Market Share by Application (2025-2030)
Table 68. Global Agomelatine Price (US$/Pcs) by Application (2019-2024)
Table 69. Global Agomelatine Price (US$/Pcs) by Application (2025-2030)
Table 70. Servier Corporation Information
Table 71. Servier Description and Business Overview
Table 72. Servier Agomelatine Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 73. Servier Agomelatine Product
Table 74. Servier Recent Developments/Updates
Table 75. Rovi Pharma Corporation Information
Table 76. Rovi Pharma Description and Business Overview
Table 77. Rovi Pharma Agomelatine Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 78. Rovi Pharma Agomelatine Product
Table 79. Rovi Pharma Recent Developments/Updates
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Agomelatine Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 83. Novartis Agomelatine Product
Table 84. Novartis Recent Developments/Updates
Table 85. Nectid Inc Corporation Information
Table 86. Nectid Inc Description and Business Overview
Table 87. Nectid Inc Agomelatine Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 88. Nectid Inc Agomelatine Product
Table 89. Nectid Inc Recent Developments/Updates
Table 90. Jiangsu Haosen Pharmaceutical Group Corporation Information
Table 91. Jiangsu Haosen Pharmaceutical Group Description and Business Overview
Table 92. Jiangsu Haosen Pharmaceutical Group Agomelatine Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 93. Jiangsu Haosen Pharmaceutical Group Agomelatine Product
Table 94. Jiangsu Haosen Pharmaceutical Group Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Agomelatine Distributors List
Table 98. Agomelatine Customers List
Table 99. Agomelatine Market Trends
Table 100. Agomelatine Market Drivers
Table 101. Agomelatine Market Challenges
Table 102. Agomelatine Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Agomelatine
Figure 2. Global Agomelatine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Agomelatine Market Share by Type in 2023 & 2030
Figure 4. Serotonin 2C Agonist Product Picture
Figure 5. Melatonin Receptor 2 Agonist Product Picture
Figure 6. Melatonin Receptor 1 Agonist Product Picture
Figure 7. Serotonin Receptor Agonist Product Picture
Figure 8. Serotonin 2C Receptor Antagonist Product Picture
Figure 9. Global Agomelatine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Agomelatine Market Share by Application in 2023 & 2030
Figure 11. Depression
Figure 12. Obsessive Compulsive Disorder
Figure 13. Sleep Disorders
Figure 14. Generalized Anxiety Disorder
Figure 15. Multiple Sclerosis
Figure 16. Systemic Traumatic Pain
Figure 17. Autism
Figure 18. Other
Figure 19. Global Agomelatine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 20. Global Agomelatine Market Size (2019-2030) & (US$ Million)
Figure 21. Global Agomelatine Sales (2019-2030) & (M Pcs)
Figure 22. Global Agomelatine Average Price (US$/Pcs) & (2019-2030)
Figure 23. Agomelatine Report Years Considered
Figure 24. Agomelatine Sales Share by Manufacturers in 2023
Figure 25. Global Agomelatine Revenue Share by Manufacturers in 2023
Figure 26. The Global 5 and 10 Largest Agomelatine Players: Market Share by Revenue in 2023
Figure 27. Agomelatine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 28. Global Agomelatine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 29. North America Agomelatine Sales Market Share by Country (2019-2030)
Figure 30. North America Agomelatine Revenue Market Share by Country (2019-2030)
Figure 31. U.S. Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Canada Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Europe Agomelatine Sales Market Share by Country (2019-2030)
Figure 34. Europe Agomelatine Revenue Market Share by Country (2019-2030)
Figure 35. Germany Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. France Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. U.K. Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Italy Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Russia Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Asia Pacific Agomelatine Sales Market Share by Region (2019-2030)
Figure 41. Asia Pacific Agomelatine Revenue Market Share by Region (2019-2030)
Figure 42. China Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Japan Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. South Korea Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. India Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Australia Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Taiwan Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Indonesia Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Thailand Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Malaysia Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Philippines Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Latin America Agomelatine Sales Market Share by Country (2019-2030)
Figure 53. Latin America Agomelatine Revenue Market Share by Country (2019-2030)
Figure 54. Mexico Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Brazil Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Argentina Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Middle East & Africa Agomelatine Sales Market Share by Country (2019-2030)
Figure 58. Middle East & Africa Agomelatine Revenue Market Share by Country (2019-2030)
Figure 59. Turkey Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 60. Saudi Arabia Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 61. UAE Agomelatine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 62. Global Sales Market Share of Agomelatine by Type (2019-2030)
Figure 63. Global Revenue Market Share of Agomelatine by Type (2019-2030)
Figure 64. Global Agomelatine Price (US$/Pcs) by Type (2019-2030)
Figure 65. Global Sales Market Share of Agomelatine by Application (2019-2030)
Figure 66. Global Revenue Market Share of Agomelatine by Application (2019-2030)
Figure 67. Global Agomelatine Price (US$/Pcs) by Application (2019-2030)
Figure 68. Agomelatine Value Chain
Figure 69. Agomelatine Production Process
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Distributors Profiles
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
